Fujian Aonong Biological Technology Group Incorporation Limited Share Price

Equities

603363

CNE100002VK6

Fishing & Farming

End-of-day quote Shanghai S.E. 03:30:00 05/07/2024 am IST 5-day change 1st Jan Change
3.94 CNY +3.41% Intraday chart for Fujian Aonong Biological Technology Group Incorporation Limited +7.07% -35.09%

Financials

Sales 2024 * 31.99B 4.4B 367B Sales 2025 * 34.52B 4.75B 397B Capitalization 3.43B 472M 39.38B
Net income 2024 * 1.47B 202M 16.87B Net income 2025 * 1.36B 187M 15.64B EV / Sales 2024 * 0.11 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.1 x
P/E ratio 2024 *
2.33 x
P/E ratio 2025 *
2.53 x
Employees 8,759
Yield 2024 *
-
Yield 2025 *
-
Free-Float 47.07%
More Fundamentals * Assessed data
Dynamic Chart
Fujian Aonong Biological Technology Group Incorporation Limited(SHSE:603363) dropped from Shanghai Stock Exchange Composite Index CI
Fujian Aonong Biological Technology Group Incorporation Limited(SHSE:603363) dropped from Shanghai Stock Exchange A Share Index CI
Zhangzhou Hongfeng Agricultural Technology Co., Ltd. cancelled the acquisition of 51% stake in Fujian Aoxin Biotechnology Group Co., Ltd. from Fujian Aonong Biological Technology Group Incorporation Limited. CI
Aonong Biological Technology's Overdue Debt Reaches 383 Million Yuan MT
Aonong Biological Technology's Pig Sales Volume Drops 64% in April MT
Fujian Aonong Biological Technology Group Incorporation Limited(XSSC:603363) dropped from S&P Global BMI Index CI
Aonong Biological Technology Faces 278 Million Yuan in Litigation, Arbitration Cases; Shares Down 5% MT
Aonong Biological Technology's Debt Reaches 157 Million Yuan in April; Shares Down 5% MT
Aonong Biological Technology Scraps Planned Divestment of Majority Stake in Aoxin Biotechnology MT
Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Aonong Biological Technology's Overdue Debts Total 277.5 Million Yuan; Shares Up 10% MT
Fujian Aonong Biological Technology Group Incorporation Limited cancelled the transaction announced on November 25, 2022 CI
Pingtan Tiantian Asset Management Co., Ltd. cancelled the acquisition of 5.2% stake in Fujian Aonong Biological Technology Group Incorporation Limited from Xiamen Aonong Investment Co., Ltd. CI
Xiamen ITG Agricultural Products Co., Ltd. agreed to acquire 49% stake in Xiamen ITG Aonong Agricultural Products Co., Ltd. from Fujian Aonong Biological Technology Group Incorporation Limited for CNY 52.2 million. CI
More news
1 day+3.41%
1 week+7.07%
Current month+5.91%
1 month-14.35%
3 months-24.67%
6 months-33.11%
Current year-35.09%
More quotes
1 week
3.65
Extreme 3.65
4.03
1 month
3.46
Extreme 3.46
4.44
Current year
2.38
Extreme 2.38
6.70
1 year
2.38
Extreme 2.38
10.09
3 years
2.38
Extreme 2.38
28.49
5 years
2.38
Extreme 2.38
28.49
10 years
2.38
Extreme 2.38
28.49
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 01/11/01
Members of the board TitleAgeSince
Director/Board Member 58 25/21/25
Director/Board Member 57 25/21/25
Chief Executive Officer 46 01/11/01
More insiders
Date Price Change Volume
05/24/05 3.94 +3.41% 19,478,640
04/24/04 3.81 -4.99% 23,499,080
03/24/03 4.01 +2.04% 15,166,590
02/24/02 3.93 +0.51% 19,325,000
01/24/01 3.91 +5.11% 21,827,240

End-of-day quote Shanghai S.E., July 05, 2024

More quotes
Fujian Aonong Biological Technology Group Incorporation Ltd is a China-based company mainly engaged in feed business. The Company's main businesses include feed business, pig breeding business, pig slaughtering and food processing business. The pig breeding business mainly sells piglets, fattening pigs and breeding pigs. The main products of the feed business include pig feed, poultry feed, aquatic feed, ruminant feed and other varieties. The pig slaughtering and food processing business mainly provides pork and meat products. The Company is also engaged in veterinary medicine, animal health, trade and other businesses. The Company mainly operates its businesses in the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.94
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603363 Stock